Skip to content

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو | English

facebook
twitter
envelope

Menu

About Us
Therapeutic Goods
Safety Info
News & Updates
Publications
E-Services
- MIS Systems
- Online Data Verification
Support
Medicine Availability

Home > Safety Info > Safety Communication > Safety Alerts > Safety Alert of Risk of severe cutaneous adverse reactions with Cefotaxime

Safety Alert of Risk of severe cutaneous adverse reactions with Cefotaxime

Abdul Qadir Safety Alerts April 7, 2025April 7, 2025

Safety-Alert-of-Risk-of-severe-cutaneous-adverse-reactions-with-Cefotaxime Download

Share this:

Twitter
Facebook

← Safety Alert risk of severe chemical irritation and damage to tissues with
Promethazine hydrochloride injection
Amended Drug Pricing Policy 2018 →

Product Recalls
Safety Communication
Safety Reporting
Report a Problem

Quick Navigation

Quick Navigation

Archives

Archives

Drug Regulatory Authority of Pakistan

Islamabad | Karachi | Lahore | Peshawar | Quetta
Phone: 0800-03727 (Mon to Fri 08:00AM to 04:00PM)
Website: www.dra.gov.pk

Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan

Contact Us
Report a Problem